Viewpoint Molecular Targeting

Viewpoint Molecular Targeting is a radiopharmaceutical company dedicated to developing precision oncology therapeutics and companion diagnostic imaging agents. The company’s leading alpha particle radiotherapy aims to deliver potent alpha radiation specifically to cancer cells using specialized targeting peptides. Viewpoint is also developing complementary diagnostic agents utilizing the same targeting peptides, offering the potential for personalized treatment and optimized patient outcomes. This "theranostic" approach allows for the visualization of specific tumors before treating them, potentially enhancing efficacy and minimizing the toxicity associated with many other types of cancer treatments.